Cargando…

Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model—In Vivo and In Vitro Study

Recent findings have highlighted the roles of CXC chemokine family in the mechanisms of neuropathic pain. Our studies provide evidence that single/repeated intrathecal administration of CXCR2 (NVP-CXCR2-20) and CXCR3 ((±)-NBI-74330) antagonists explicitly attenuated mechanical/thermal hypersensitivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piotrowska, Anna, Ciapała, Katarzyna, Pawlik, Katarzyna, Kwiatkowski, Klaudia, Rojewska, Ewelina, Mika, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538855/ https://www.ncbi.nlm.nih.gov/pubmed/34681732 http://dx.doi.org/10.3390/ijms222011074

Ejemplares similares

Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain
por: Piotrowska, Anna, et al.
Publicado: (2018)

Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury
por: Piotrowska, Anna, et al.
Publicado: (2019)

Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain
por: Pawlik, Katarzyna, et al.
Publicado: (2021)

Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain
por: Zajaczkowska, Renata, et al.
Publicado: (2020)

Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model
por: Rojewska, Ewelina, et al.
Publicado: (2018)

New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies
por: Ciechanowska, Agata, et al.
Publicado: (2022)

Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain
por: Ciapała, Katarzyna, et al.
Publicado: (2023)

Pharmacological Evidence of the Important Roles of CCR1 and CCR3 and Their Endogenous Ligands CCL2/7/8 in Hypersensitivity Based on a Murine Model of Neuropathic Pain
por: Pawlik, Katarzyna, et al.
Publicado: (2022)

The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives
por: Ciapała, Katarzyna, et al.
Publicado: (2021)

Mirogabalin Decreases Pain-like Behaviors by Inhibiting the Microglial/Macrophage Activation, p38MAPK Signaling, and Pronociceptive CCL2 and CCL5 Release in a Mouse Model of Neuropathic Pain
por: Zajączkowska, Renata, et al.
Publicado: (2023)

Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain
por: Zajączkowska, Renata, et al.
Publicado: (2022)

Botulinum Toxin Type A—A Modulator of Spinal Neuron–Glia Interactions under Neuropathic Pain Conditions
por: Rojewska, Ewelina, et al.
Publicado: (2018)

The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats
por: Kwiatkowski, Klaudia, et al.
Publicado: (2017)

Pharmacological Modulation of the MIP-1 Family and Their Receptors Reduces Neuropathic Pain Symptoms and Influences Morphine Analgesia: Evidence from a Mouse Model
por: Ciechanowska, Agata, et al.
Publicado: (2023)

Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy
por: Kwiatkowski, Klaudia, et al.
Publicado: (2020)

CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain
por: Bogacka, Joanna, et al.
Publicado: (2020)

Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain
por: Pawlik, Katarzyna, et al.
Publicado: (2023)

Minocycline Enhances the Effectiveness of Nociceptin/Orphanin FQ during Neuropathic Pain
por: Popiolek-Barczyk, Katarzyna, et al.
Publicado: (2014)

Delta-Opioid Receptor Analgesia Is Independent of Microglial Activation in a Rat Model of Neuropathic Pain
por: Mika, Joanna, et al.
Publicado: (2014)

CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy
por: Bogacka, Joanna, et al.
Publicado: (2022)

Advances in Neuropathic Pain Research: Selected Intracellular Factors as Potential Targets for Multidirectional Analgesics
por: Ciapała, Katarzyna, et al.
Publicado: (2023)

Phenytoin Decreases Pain-like Behaviors and Improves Opioid Analgesia in a Rat Model of Neuropathic Pain
por: Kocot-Kępska, Magdalena, et al.
Publicado: (2023)

Neuropathic Pain Dysregulates Gene Expression of the Forebrain Opioid and Dopamine Systems
por: Wawrzczak-Bargieła, Agnieszka, et al.
Publicado: (2020)

Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain
por: Rojewska, Ewelina, et al.
Publicado: (2014)

Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo
por: Meijer, J, et al.
Publicado: (2008)

Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo
por: Meijer, J, et al.
Publicado: (2011)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model
por: Jurga, Agnieszka M., et al.
Publicado: (2016)

Computer‐aided assessment of the chemokine receptors CXCR3, CXCR4 and CXCR7 expression in gallbladder carcinoma
por: Yu, Xiao, et al.
Publicado: (2020)

CXCR1/2 pathways in paclitaxel-induced neuropathic pain
por: Laura, Brandolini, et al.
Publicado: (2017)

Pharmacological Inhibition of CXCR2 Chemokine Receptors Modulates Paraquat-Induced Intoxication in Rats
por: Costa, Kesiane M., et al.
Publicado: (2014)

Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands
por: Moussouras, Natasha A., et al.
Publicado: (2017)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020)

Agonists for the Chemokine Receptor CXCR4
por: Lefrançois, Marilou, et al.
Publicado: (2011)

Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice
por: Zhang, Qian, et al.
Publicado: (2016)

Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes
por: Nojima, Hiroyuki, et al.
Publicado: (2016)

Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
por: Chifu, Irina, et al.
Publicado: (2020)

The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML)
por: Korbecki, Jan, et al.
Publicado: (2023)

CXCR4 chemokine receptor signaling mediates pain in diabetic neuropathy
por: Menichella, Daniela Maria, et al.
Publicado: (2014)

Regulation of the Chemokine Receptor CXCR4 by Hypoxia
por: Schioppa, Tiziana, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_cjtir9clbqj3d4q9e3cgpagcjb